aortic valve implant services
Research & Development Milestones
Colibri recently initiated a clinical early feasibility study (EFS) which is an international prospective, non-randomized, single arm, open label, trial to assess early feasibility of the Colibri second-generation 24mm and 27mm percutaneous, ready-for-use, balloon expandable aortic heart valve and delivery ...
By Colibri Heart Valve LLC based in Louisville, COLORADO (USA).
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you